Aims

OBM Transplantation (ISSN 2577-5820) is an international peer-reviewed Open Access journal published quarterly online by LIDSEN Publishing Inc., which covers all evidence-based scientific studies related to transplantation, including: transplantation procedures and the maintenance of transplanted tissues or organs; assimilation of grafted tissue and the reconstitution of removed organs or parts of organs; transplantation of heart, lung, kidney, liver, pancreatic islets and bone marrow, etc. Areas related to clinical and experimental transplantation are also of interest. OBM Transplantation is committed to rapid review and publication, and we aim at serving the international transplant community with high accessibility as well as relevant and high quality content. The journal publishes all types of articles in English. There is no restriction on the length of the papers. We encourage authors to be concise but present their results in as much detail as necessary, as reviewers are expected to emphasize scientific rigor and reproducibility.

Scope

• Biomarkers in transplantation
• Cell transplantation
• Cellular therapies
• Donor specific antibody
• Ethical and legal issues in transplantation
• Organ donation
• Organ transplantation
• Transplant immunology
• Transplantation tolerance
• Xenotransplantation
• Diets and transplantation

LIDSEN Publication Ethics Statement

OBM Transplantation is a member of the Committee on Publication Ethics (COPE). We strictly adhere to the code of publication ethics set forth by COPE and deal with suspected ethical issues in accordance with its Core Practices.

Submitted articles are required to comply with Editorial Process and Quality Control, Research and Publication Ethics Guidelines, and Instructions for Authors, and rigorous and thorough peer review processes will be conducted to enforce high-quality articles. To verify the originality of content submitted to the journal, we run an assay using iThenticate to check the similarity of submissions against previously published works. We are committed to ensuring that any potential ethical issues realized or pointed out, regardless of whether the manuscript is in the peer-review stage, has been accepted, or has been published, will be investigated and managed following a standard process.

Copyright License and Open Access

Articles in OBM Transplantation will be Open-Access published under the Creative Commons Attribution (CC BY 4.0) License, unless otherwise noted. The copyright is retained by the author(s). Under this license, authors agree to make articles, including data, graphics, and supplements, legally available for reuse, without permission or fees, for virtually any purpose. Any individual or institution is free to copy, distribute, reproduce, or reuse these publications, as long as the author and original source are properly cited.

Please note that some articles (especially Reviews) may contain figures, tables or text taken from other publications, for which OBM Transplantation does not hold the copyright or the right to re-license the published material. You should inquire with the original copyright holder (usually the original publisher or authors), whether or not this material can be re-used.

All the papers that are published in OBM Transplantation contain a note:

© 2024 by the authors. This is an open access article distributed under the conditions of the Creative Commons by Attribution License, which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is correctly cited.

Announcement

Announcements regarding academic conferences are published for free in the Conferences section of the journal. Please contact us at transplantation@lidsen.com.

Editorial Office

Ms. Jessy Wang
Managing Editor

For further OBM Transplantation contacts, see here.